Years later, this breakthrough would be the key to delivering Moderna's mRNA vaccine into the targeted cells that would trigger an immune response in the body.
[...] Northwestern inventors at the school's International Institute for Nanotechnology (IIN) pioneered the technology for a 'vehicle for delivering genetic code into a cell by harnessing attributes of naturally-occurring structures, called lipoproteins' through research beginning in the late 2000s.
Moderna had notice of the infringement as of October 2023, says the complaint, but has continued to infringe, and has publicly stated its plans to develop additional products that are likely to infringe.
According to the complaint, 'each of these patents cite to a family member with the same disclosures as those of the Asserted Patents.'
Collection
[
|
...
]